IL-1 Blockade: A Treatment at Last for Osteoarthritis?

(MedPage Today) -- The interleukin (IL)-1β inhibitor canakinumab (Ilaris) showed promise for preventing the need for hip or knee replacement among patients with osteoarthritis in an exploratory analysis of data from a randomized clinical trial...